logo

For the Inventor, By the Inventor

Pomezia, Italy

Natalina Dell'Uomo

This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignee: Sigma-Tau Industrie Farmaceutiche Riunite S.p.a.. Active years: 2003-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Natalina Dell'Uomo. Retrieved from https://idiyas.com/inventor/natalina-dell-uomo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3

% Patents Active = 33.3


Average Co-Inventor Count = 4.8

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:

goldMedal3 out of 343 
 
Sigma-Tau Industrie Farmaceutiche Riunite S.p.a.
 patents

Years Active: 2003-2008

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents
1. 7375124 - Use of α-phenylthiocarboxylic and α-phenyloxycarboxylic acids with serum-glucose-lowering and serum-lipid-lowering activity (2008-05-20),
2. 6822115 - Synthesis of (R) and (S)-aminocarnitine, (R) and (S)-4-phosphonium-3-amino-butanoate, (R) and (S) 3,4-diaminobutanoic acid, and their derivatives starting from D- and L-aspartic acid (2004-11-23),
3. 6528684 - Synthesis of (R) and (S) -aminocarnitine and their derivatives starting from D- and L-aspartic acid (2003-03-04),

Title: Natalina Dell'Uomo: Innovator in Pharmaceutical Chemistry

Introduction

Natalina Dell'Uomo is a prominent inventor based in Pomezia, Italy. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds aimed at treating diabetes and related conditions. With a total of 3 patents, her work has garnered attention in the scientific community.

Latest Patents

Dell'Uomo's latest patents include innovative methods for utilizing α-phenylthiocarboxylic and α-phenyloxycarboxylic acids. These compounds are described for their serum-glucose-lowering and serum-lipid-lowering activities, particularly in the context of type 2 diabetes and its complications. Another notable patent involves the synthesis of (R) and (S)-aminocarnitine, (R) and (S)-4-phosphonium-3-amino-butanoate, and (R) and (S)-3,4-diaminobutanoic acid, along with their derivatives, starting from D- and L-aspartic acid.

Career Highlights

Dell'Uomo is currently associated with Sigma-Tau Industrie Farmaceutiche Riunite S.p.a., where she continues to advance her research and development efforts. Her work is characterized by a commitment to improving therapeutic options for patients suffering from metabolic disorders.

Collaborations

Throughout her career, Dell'Uomo has collaborated with esteemed colleagues, including Fabio Giannessi and Maria Ornella Tinti. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Natalina Dell'Uomo's contributions to pharmaceutical chemistry exemplify the impact of innovative research on healthcare. Her patents reflect a dedication to addressing critical health issues, particularly in diabetes management.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…